Company Profiles

driven by the PitchBook Platform

Genkyotex

Description

Developer of NADPH oxidases (NOX) inhibitors for the treatment of oxidative stress. The company's medicines help to treat diseases such as diabetic hypertension, myocardial infarction, Alzheimer's disease and Parkinson's disease.

2006

Founded

PRIVATE

Status

11-50

Employees

Series D

Latest Deal Type

$21M

Latest Deal Amount

$72.8M

Total Amount Raised

Description

Developer of NADPH oxidases (NOX) inhibitors for the treatment of oxidative stress. The company's medicines help to treat diseases such as diabetic hypertension, myocardial infarction, Alzheimer's disease and Parkinson's disease.

Website:

www.genkyotex.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Discovery Tools (Healthcare)

Primary Office

16, Chemin des Aulx 1228 Plan-les-OuatesSwitzerland +41 (0)22 880 1025
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Genkyotex's full profile, request a free trial.

Genkyotex Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Genkyotex Investors (9)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BioMedPartnersVenture CapitalMinority000 0000000 0000
EclosionAccelerator/IncubatorMinority000 0000000 0000
Edmond de Rothschild Investment PartnersVenture CapitalMinority000 0000000 0000
Fondation d'Aide aux EntreprisesCorporationMinority000 0000000 0000
MP Healthcare Venture ManagementVenture CapitalMinority000 0000000 0000
BioMedPartners Venture Capital
Eclosion Accelerator/Incubator
Edmond de Rothschild Investment Partners Venture Capital
Fondation d'Aide aux Entreprises Corporation
MP Healthcare Venture Management Venture Capital

Genkyotex Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Elias PapatheodorouChief Executive Officer
Alexandre GrassinDirector of Finance and Administration
Philippe Wiesel MDChief Medical Officer & Executive Vice President
Karl-Heinz Krause MDFounder & Board Member
Stephanie Carnesecchi acker Ph.DHead of Cell Signalling pathways & Biomarkers
Elias Papatheodorou Chief Executive Officer
Alexandre Grassin Director of Finance and Administration
Philippe Wiesel MD Chief Medical Officer & Executive Vice President
Karl-Heinz Krause MD Founder & Board Member
Stephanie Carnesecchi acker Ph.D Head of Cell Signalling pathways & Biomarkers

Genkyotex Board Members (11)

NameRepresentingRoleSinceContact
Info
Claudio Nessi Ph.DNeoMed ManagementManaging Partner000 0000
Diego Braguglia Ph.DVI PartnersGeneral Partner000 0000
Eric ViaudSelfBoard Observer000 0000
Ernest Loumaye Ph.DSelfChairman000 0000
Gilles NobécourtEdmond de Rothschild Investment PartnersInvestment Manager000 0000
Claudio Nessi Ph.D Managing Partner NeoMed Management
Diego Braguglia Ph.D General Partner VI Partners
Eric Viaud Board Observer Self
Ernest Loumaye Ph.D Chairman Self
Gilles Nobécourt Investment Manager Edmond de Rothschild Investment Partners
Request full access to PitchBook